Results: 1-25 | 26-39
Results: 1-25/39
A-BETA-42 DEPOSITION PRECEDES OTHER CHANGES IN PS-1 ALZHEIMERS-DISEASE
Authors: LIPPA CF NEE LE MORI H STGEORGEHYSLOP P
Citation: Cf. Lippa et al., A-BETA-42 DEPOSITION PRECEDES OTHER CHANGES IN PS-1 ALZHEIMERS-DISEASE, Lancet, 352(9134), 1998, pp. 1117-1118
ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE
Authors: FLANDERS KC LIPPA CF SMITH TW POLLEN DA SPORN MB
Citation: Kc. Flanders et al., ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE, Neurology, 45(8), 1995, pp. 1561-1569
ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE
Authors: FLANDERS KC LIPPA CF POLLEN DA SPORN MB
Citation: Kc. Flanders et al., ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE, Journal of cellular biochemistry, 1995, pp. 103-103
ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY
Authors: LIPPA CF SMITH TW SWEARER JM
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY, Annals of neurology, 35(1), 1994, pp. 81-88
ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY (VOL 35, PG 81, 1994)
Authors: LIPPA CF SMITH TW SWEARER JM
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY (VOL 35, PG 81, 1994), Annals of neurology, 35(3), 1994, pp. 380-380
ALZHEIMERS-DISEASE AND POSSIBLE GENE INTERACTION
Authors: STGEORGEHYSLOP P MCLACHLAN DC TUDA T ROGAEV E KARLINSKY H LIPPA CF POLLEN D
Citation: P. Stgeorgehyslop et al., ALZHEIMERS-DISEASE AND POSSIBLE GENE INTERACTION, Science, 263(5146), 1994, pp. 537-537
ALZHEIMERS-DISEASE, LEWY BODY DISEASE AND AGING - A COMPARATIVE-STUDYOF THE PERFORANT PATHWAY
Authors: LIPPA CF PULASKISALO D DICKSON DW SMITH TW
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE, LEWY BODY DISEASE AND AGING - A COMPARATIVE-STUDYOF THE PERFORANT PATHWAY, Journal of the neurological sciences, 147(2), 1997, pp. 161-166
ALZHEIMERS-DISEASE VERSUS LEWY BODY DISEASE - DIFFERENCES IN PERFORANT PATHWAY PATHOLOGY
Authors: LIPPA CF SMITH TW PULASKISALO D DICKSON DW
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE VERSUS LEWY BODY DISEASE - DIFFERENCES IN PERFORANT PATHWAY PATHOLOGY, Annals of neurology, 40(3), 1996, pp. 47-47
ALZHEIMERS-DISEASE WITH AND WITHOUT LEWY BODIES - CAN THEY BE DISTINGUISHED AT INITIAL PRESENTATION
Authors: LIPPA CF SWEARER J SALO D DRACHMAN DA
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE WITH AND WITHOUT LEWY BODIES - CAN THEY BE DISTINGUISHED AT INITIAL PRESENTATION, Annals of neurology, 38(2), 1995, pp. 290-290
APOLIPOPROTEIN E-EPSILON-2 AND ALZHEIMERS-DISEASE - GENOTYPE INFLUENCES PATHOLOGICAL PHENOTYPE
Authors: LIPPA CF SMITH TW SAUNDERS AM HULETTE C PULASKISALO D ROSES AD
Citation: Cf. Lippa et al., APOLIPOPROTEIN E-EPSILON-2 AND ALZHEIMERS-DISEASE - GENOTYPE INFLUENCES PATHOLOGICAL PHENOTYPE, Neurology, 48(2), 1997, pp. 515-519
APOLIPOPROTEIN-E EPSILON-4 ALLELE AND THE LIFETIME RISK OF ALZHEIMERS-DISEASE - WHAT PHYSICIANS KNOW, ANN WHAT THEY SHOULD KNOW
Authors: SESHADRI S DRACHMAN DA LIPPA CF
Citation: S. Seshadri et al., APOLIPOPROTEIN-E EPSILON-4 ALLELE AND THE LIFETIME RISK OF ALZHEIMERS-DISEASE - WHAT PHYSICIANS KNOW, ANN WHAT THEY SHOULD KNOW, Archives of neurology, 52(11), 1995, pp. 1074-1079
APOLIPOPROTEIN-E GENOTYPE AND LEWY BODY DISEASE
Authors: LIPPA CF SMITH TW SAUNDERS AM CROOK R PULASKISALO D DAVIES P HARDY J ROSES AD DICKSON D
Citation: Cf. Lippa et al., APOLIPOPROTEIN-E GENOTYPE AND LEWY BODY DISEASE, Neurology, 45(1), 1995, pp. 97-103
APOLIPOPROTEIN EPSILON-2 IN AGING AND ALZHEIMERS-DISEASE - GENOTYPE INFLUENCES A-BETA PLAQUE PATHOLOGY
Authors: LIPPA CF SMITH TW SAUNDERS AM PULASKISALO D ROSES AD
Citation: Cf. Lippa et al., APOLIPOPROTEIN EPSILON-2 IN AGING AND ALZHEIMERS-DISEASE - GENOTYPE INFLUENCES A-BETA PLAQUE PATHOLOGY, Journal of neuropathology and experimental neurology, 54(3), 1995, pp. 427-427
BETA-AMYLOID-40 AND BETA-AMYLOID-42 DEPOSITION IN DEMENTIA WITH LEWY BODIES - COMPARISON WITH ALZHEIMERS-DISEASE AND AGING
Authors: LIPPA CF BREEN A OCONNELL B SMITH TW MORI H
Citation: Cf. Lippa et al., BETA-AMYLOID-40 AND BETA-AMYLOID-42 DEPOSITION IN DEMENTIA WITH LEWY BODIES - COMPARISON WITH ALZHEIMERS-DISEASE AND AGING, Neurology, 50(4), 1998, pp. 13005-13005
DEMENTIA WITH LEWY BODIES - INFLUENCE OF APOE GENOTYPE ON A-BETA(-40)AND A-BETA(-42) DEPOSITION
Authors: LIPPA CF OCONNELL B SMITH TW ISHII K MORI H
Citation: Cf. Lippa et al., DEMENTIA WITH LEWY BODIES - INFLUENCE OF APOE GENOTYPE ON A-BETA(-40)AND A-BETA(-42) DEPOSITION, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 186-186
DEMENTIA WITH PARKINSONISM - ALZHEIMERS-DISEASE OR LEWY BODY DISEASE
Authors: LIPPA CF OCONNELL B NEE L SMITH TW
Citation: Cf. Lippa et al., DEMENTIA WITH PARKINSONISM - ALZHEIMERS-DISEASE OR LEWY BODY DISEASE, Neurology, 48(3), 1997, pp. 14005-14005
DIFFUSE LEWY BODY DISEASE - EXCESSIVE BETA-AMYLOID DEPOSITION WITHOUTNEURONAL LOSS
Authors: LIPPA CF SMITH TW
Citation: Cf. Lippa et Tw. Smith, DIFFUSE LEWY BODY DISEASE - EXCESSIVE BETA-AMYLOID DEPOSITION WITHOUTNEURONAL LOSS, Neurology, 43(4), 1993, pp. 252-252
ESTROGEN AND ALZHEIMERS-DISEASE - COULD THE TGF-BETA SYSTEM BE INVOLVED
Authors: DUDA J LIPPA CF CROUL S NEE L FLANDERS K
Citation: J. Duda et al., ESTROGEN AND ALZHEIMERS-DISEASE - COULD THE TGF-BETA SYSTEM BE INVOLVED, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 106-106
FAMILIAL ALZHEIMERS-DISEASE AND CORTICAL LEWY BODIES - IS THERE A GENETIC SUSCEPTIBILITY FACTOR
Authors: LIPPA CF SMITH TW NEE L ROBITAILLE Y CRAIN B DICKSON D PULASKISALO D POLLEN DA
Citation: Cf. Lippa et al., FAMILIAL ALZHEIMERS-DISEASE AND CORTICAL LEWY BODIES - IS THERE A GENETIC SUSCEPTIBILITY FACTOR, Dementia, 6(4), 1995, pp. 191-194
FAMILIAL ALZHEIMERS-DISEASE - DO DIFFERENT GENOTYPES CAUSE THE SAME NEUROPATHOLOGY
Authors: LIPPA CF POLLEN DA SMITH TW PULASKISALO D ZAIK J DRACHMAN DA SWEARER J SAINTGEORGEHYSLOP P BERGERON C ROBITAILLE Y ROSES A SAUNDERS A HYMAN B NEE L CRAIN B DICKSON D
Citation: Cf. Lippa et al., FAMILIAL ALZHEIMERS-DISEASE - DO DIFFERENT GENOTYPES CAUSE THE SAME NEUROPATHOLOGY, Neurology, 44(4), 1994, pp. 10000387-10000387
FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE - NEUROPATHOLOGY CANNOT EXCLUDE A FINAL COMMON PATHWAY
Authors: LIPPA CF SAUNDERS AM SMITH TW SWEARER JM DRACHMAN DA GHETTI B NEE L PULASKISALO D DICKSON D ROBITAILLE Y BERGERON C CRAIN B BENSON MD FARLOW M HYMAN BT STGEORGEHYSLOP P ROSES AD POLLEN DA
Citation: Cf. Lippa et al., FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE - NEUROPATHOLOGY CANNOT EXCLUDE A FINAL COMMON PATHWAY, Neurology, 46(2), 1996, pp. 406-412
GLIAL-MICROGLIAL INTERACTIONS AND THE HOST INFLAMMATORY RESPONSE IN PICKS-DISEASE
Authors: GALVIN JE LIPPA CF
Citation: Je. Galvin et Cf. Lippa, GLIAL-MICROGLIAL INTERACTIONS AND THE HOST INFLAMMATORY RESPONSE IN PICKS-DISEASE, Neurology, 50(4), 1998, pp. 3007-3007
IMMUNOEXPRESSION OF A POLYCLONAL ANTIBODY-DIRECTED AGAINST THE S182 AND E5-1 PROTEINS
Authors: LIPPA CF FRASER PE NEE L ALEXANDER M SALO D STGEORGEHYSLOP P
Citation: Cf. Lippa et al., IMMUNOEXPRESSION OF A POLYCLONAL ANTIBODY-DIRECTED AGAINST THE S182 AND E5-1 PROTEINS, Annals of neurology, 38(6), 1995, pp. 6-6
INDUCIBLE NITRIC-OXIDE SYNTHASE IN TANGLE-BEARING NEURONS OF PATIENTSWITH ALZHEIMERS-DISEASE
Authors: VODOVOTZ Y LUCIA MS FLANDERS KC CHESLER L XIE QW SMITH TW WEIDNER J MUMFORD R WEBBER R NATHAN C ROBERTS AB LIPPA CF SPORN MB
Citation: Y. Vodovotz et al., INDUCIBLE NITRIC-OXIDE SYNTHASE IN TANGLE-BEARING NEURONS OF PATIENTSWITH ALZHEIMERS-DISEASE, The Journal of experimental medicine, 184(4), 1996, pp. 1425-1433
KI-67 IMMUNOREACTIVITY IN ALZHEIMERS-DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
Authors: SMITH TW LIPPA CF
Citation: Tw. Smith et Cf. Lippa, KI-67 IMMUNOREACTIVITY IN ALZHEIMERS-DISEASE AND OTHER NEURODEGENERATIVE DISORDERS, Journal of neuropathology and experimental neurology, 54(3), 1995, pp. 297-303
Risultati: 1-25 | 26-39